Evidence map›Paper›PMID 39699897›Full record

ArticleJAMA network open2024

Evolution in Documented Goals of Care at End of Life for Adolescents and Younger Adults With Cancer.

Rosemarie Mastropolo, Colin Cernik, Hajime Uno, Lauren Fisher, Lanfang Xu, Cecile A Laurent, Nancy Cannizzaro, Julie Munneke, Robert M Cooper, Joshua R Lakin and 7 more

Abstract read
In one paragraph

Article in JAMA network open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Rosemarie MastropoloDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Colin CernikDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Hajime UnoDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Lauren FisherDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
Lanfang XuMedHealth Statistical Consulting Inc, Solon, Ohio.
Cecile A LaurentDivision of Research, Kaiser Permanente Northern California, Oakland.
Nancy CannizzaroDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Julie MunnekeDivision of Research, Kaiser Permanente Northern California, Oakland.
Robert M CooperDepartment of Pediatric Oncology, Kaiser Permanente Southern California, Pasadena.
Joshua R LakinDepartment of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, Massachusetts.
Corey M SchwartzDivision of Medical Oncology, Kaiser Permanente Northern California, Oakland.
Mallory CaspersonCactus Cancer Society, Oakland, California.
Andrea AltschulerDivision of Research, Kaiser Permanente Northern California, Oakland.
Lawrence KushiDivision of Research, Kaiser Permanente Northern California, Oakland.
Chun R ChaoDepartment of Research and Evaluation, Kaiser Permanente Southern California, Pasadena.
Lori WienerPsychosocial Support and Research Program, National Cancer Institute, Bethesda, Maryland.
Jennifer W MackDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.

Funding

Research Training in Pediatric OncologyT32CA136432 · NCI · DANA-FARBER CANCER INST · PI SCOTT A ARMSTRONG · 2009 to 2026
$7.9M
End-of-life care quality for adolescents and young adults with cancer: Including the patient voice in quality assessmentU01CA218651 · NCI · DANA-FARBER CANCER INST · PI JENNIFER W MACK · 2019 to 2026
$3.9M
NCI NIH HHS T32 CA136432NCI NIH HHS U01 CA218651
6 · The paper itself

Abstract

Importance: Little is known about the nature of change in goals of care (GOC) over time among adolescents and younger adult (AYA) patients aged 12 to 39 years with cancer near the end of life. Understanding how GOC evolve may guide clinicians in supporting AYA patients in making end-of-life decisions. Objective: To assess frequency, timing, and evolution of documented GOC among AYA patients with cancer in the last 90 days of life. Design, Setting, and Participants: This cross-sectional study included a retrospective review of medical records from the Dana-Farber Cancer Institute, Kaiser Permanente Northern California, and Kaiser Permanente Southern California of AYA patients with cancer who were 12 to 39 years of age at death and who died between January 1, 2003, and December 31, 2019. Data were analyzed from July 1, 2023, through April 30, 2024. Exposures: Stage IV cancer or stage I-III cancer with new metastasis or recurrence. Main Outcome and Measures: The primary outcome was documented GOC discussions, categorized by timing before death as initial (>60 days), middle (31-60 days), or late (≤30 days). Goals were classified as palliative, nonpalliative, undecided, or not discussed. Subgroup analysis according to race and ethnicity were also performed. Results: Among 1929 AYA patients with a mean (SD) age at cancer diagnosis of 28 (8) years, 1049 (54.5%) were female; 5 (0.3%) were American Indian or Alaska Native, 227 (11.8%) were Asian, 157 (8.1%) were Black or African American, 14 (0.7%) were Native Hawaiian or Other Pacific Islander, 1184 (61.4%) were White, 11 (0.6%) were of more than 1 race, 38 (2.0%) were categorized as other race, 293 (15.2%) were without documented race, 514 (26.6%) were Hispanic or Latino, 762 (39.5%) were not Hispanic or Latino, and 653 (33.9%) had no documented ethnicity. Few AYA patients had palliative goals documented in the initial period (139 [7.2%]), increasing to 331 (17.2%) in the middle period and 1113 (57.7%) in the late period. In total, 393 patients (20.4%) transitioned from documented nonpalliative goals in the initial or middle periods to palliative goals by the late period. Many patients had no documented GOC discussion until close to death (initial, 1364 [70.7%]; middle, 969 [50.2%]; and late, 322 [16.7%]). Among the 1929 patients, non-White patients were disproportionately represented among those not having documented GOC discussions (Black, 30 of 157 [19.1%]; Asian, 45 of 227 [19.8%]; and other or undocumented race, 80 of 361 [22.2%]) compared with White patients (167 of 1184 [14.1%]) (P < .001) as were Hispanic or Latino patients (116 of 514 [22.6%]) compared with non-Hispanic patients (93 of 762 [12.2%]) (P < .001) and individuals with no ethnicity documented (113 of 653 [17.3%]) (P < .001). Conclusions and Relevance: In this cross-sectional study of AYA patients who died of cancer, palliative goals were rarely documented before the last month of life, highlighting the need for timely and ongoing GOC discussions.

Indexed as

NeoplasmsTerminal CareAdolescentAdultCaliforniaChildCross-Sectional StudiesFemaleHumansMalePatient Care PlanningRetrospective StudiesYoung Adult

Identifiers

PMID39699897
PMCPMC11659917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.